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Merkel cell carcinoma is a rare and highly aggressive cutaneous neuroendocrine carcinoma that , in most cases, is caused by Merkel cell polyomavirus (approximately 80% of cases). The tumor usually arises on sun-exposed skin of elderly patients, particularly on the head and neck and extremities. There is a slight female preponderance and an increased risk in individuals who are immunosuppressed. Clinically, the tumors are often indistinguishable from other skin cancers and typically present as a firm, painless, rapidly growing nodule. They may be flesh-colored, red, or blue tumors that typically vary in size from 0.5 em to more than 5 em (average, 2 em). When they have a reddish nodular appearance, they may be mistaken for angiosarcoma or granulation tissue.
The expected 5-year survival rate is more than 80% if the tumor is less than 2 ern and has not metastasized. Once a tumor has metastasized regionally, the 5-year survival rate drops to about 50%. Local recurrences occur in about one-third of cases. The tumor spreads to the regional lymph nodes in up to 75% of cases, and distant metastasis with eventual death occurs in one-third or more.
Initial treatment includes complete surgical excision along with sentinel lymph node biopsy (lymph node dissection is indicated if lymph nodes are clinically or biopsy proven positive). Sentinel lymph node biopsy is a challenge in head and neck sites, as there are frequently multiple lymph node drainage regions affected or with crossover. A sentinel lymph node biopsy detects metastasis in one-third of patients who might otherwise have been clinically and/or radiographically understaged, resulting in undertreatment.
Adjuvant radiotherapy has been shown to be effective in reducing the rate of recurrence and increasing survival. Patients with no distant metastases and a negative sentinel lymph node have a very good prognosis when treated with surgery and radiotherapy (approximately 90% survival rate at 5 years).
The tumor is composed of uniform, small, round to oval cells arranged in sheets and solid nests, usually infiltrating the entire dermis (figure 1) and sometimes extending into the subcutaneous adipose tissue. Epidermal involvement is uncommon. Focal necrosis may be seen, and mitoses and apoptotic bodies are usually numerous. The neoplastic cells have a very high nuclear-to-cytoplasmic ratio, with nuclei that are delicate and prone to crush artifacts. The nuclear chromatin is delicate, even with a salt-and-pepper distribution (figure 2). Nucleoli are small but easily identified. Mitoses are greatly increased and include atypical forms. Cannibalism of cells is noted. The histopathologic differential diagnosis mainly includes basal cell carcinoma, lymphoma, melanoma, and metastatic small cell carcinoma. Merkel cell carcinoma reacts positively for neuroendocrine markers such as synaptophysin and chromogranin, showing a characteristic perinuclear dot-like staining pattern with pan-cytokeratin and CK20 immunohistochemistry ( figure 2 ). CK20 is a particularly useful marker, as metastatic small cell carcinomas are negative for this marker. with 1:100,000 epinephrine into the planned incision. After waiting several minutes for hemostasis, use a number 11 blade with a gentle sawing motion to incise the line just anterior to the alar-facial groove. Follow this with incisions along the other lines using a number 15 blade. Connect the vestibular incision with the alar-facial incision to completely mobilize the ala. The incision on the columella should be deep enough to accept the full thickness of the alar flap. Do not cauterize any bleeding vessels as this may cause necrosis of the fibrofatty alar tissue, resulting in deformity. The wound closure will tamponade any bleeding. Inset the flap by placing a single 5-0 PDS suture from the base of the flap to the apex of the columellar incision. Follow this with 7-0 nylon vertical mattress sutures in the columella and alar-facial incisions. Use 5-0 fast-absorbing gut to close the incision in the vestibule. Dress the wound with petroleum jelly and instruct the patient to clean the sutures with peroxide twice per day and to apply petroleum jelly often enough to keep the wound moist. Remove the sutures after 5 to 7 days. Figure 2 shows the result of the Y-V alar base reduction technique.
